Simmons Remains Sidelined on Core Laboratories (CLB) - PT to $115
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq hits intraday record high on Alphabet boost, Mideast negotiation hopes
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Core Lab Reports Q1 2016 Results:
April 20, 2016 5:11 PM EDTAMSTERDAM, April 20, 2016 /PRNewswire/ -- Core Laboratories N.V. (NYSE: "CLB US") (Euronext Amsterdam: "CLB NA") ("Core", "Core Lab", or the "Company") reported first quarter 2016 earnings per diluted share ("EPS") of $0.37, excluding foreign currency translations ("ex-fx"). First quarter 2016 net income, ex-fx, was $15,700,000, and revenue was $153,600,000, down sequentially 16% from fourth quarter 2015 levels, as North America rig count decreased over 35%, resulting in global rig count falling by 21%, during the quarter. The Company believes that global spending will fall 27% in 2016. Operating income, ex-fx, was $23,700,000, yielding operating margins, ex-fx, of over 15%. In accordance with generally accepted accounting principles ("GAAP"), which included all... More
